Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Preventive Healthcare Services

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Search research articles

Home
Universal Newborn Screening For Familial Hypercholesterolaemia-insights From Healthcare Professionals In Queensland, Australia.

Home
Universal Newborn Screening For Familial Hypercholesterolaemia-insights From Healthcare Professionals In Queensland, Australia.

Related Experiment Video

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Universal newborn screening for familial hypercholesterolaemia-insights from healthcare professionals in Queensland,

Caroline Bachmeier^1,2,3, Deborah Johnston⁴, Karam Kostner^5,6

¹University of Queensland, Brisbane, QLD, Australia. c.bachmeier@uq.edu.au.

Journal of Community Genetics

|November 18, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Healthcare providers in Queensland, Australia, strongly support newborn screening for familial hypercholesterolaemia (FH). Key benefits include early diagnosis and disease prevention, though concerns about cost and genetic discrimination need addressing.

More Related Videos

Cholesterol Efflux Assay

Cholesterol Efflux Assay

Published on: March 6, 2012

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Experiment Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Cholesterol Efflux Assay

Cholesterol Efflux Assay

Published on: March 6, 2012

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Area of Science:

Medical Genetics
Public Health
Cardiovascular Disease Prevention

Background:

Familial hypercholesterolaemia (FH) is a common genetic disorder causing premature atherosclerotic cardiovascular disease.
Less than 10% of individuals with FH are identified due to challenges in screening and intervention.
Current guidelines recommend early screening and intervention for FH.

Purpose of the Study:

To evaluate healthcare provider support for introducing newborn screening for FH in Queensland, Australia.
To identify perceived benefits, concerns, barriers, and potential solutions for FH newborn screening.
To gather insights from diverse medical specialties involved in cardiovascular and genetic care.

Main Methods:

A 16-item survey was distributed to healthcare providers across Queensland.

Participants included specialists in Endocrinology, Cardiology, Chemical Pathology, Genetic Pathology, Clinical Genetics, General Practice, and Genetic Counselling.

69 healthcare providers completed the survey.

Main Results:

Strong support was found for newborn screening for FH, including via genetic testing.
Perceived benefits included early diagnosis, heart disease prevention, cascade screening, and family planning.
Concerns encompassed insurance access, genetic understanding, parental anxiety, healthcare burden, discrimination, and psychological impacts.

Conclusions:

Widespread support for FH newborn screening exists among diverse healthcare professionals in Queensland.
Addressing concerns related to cost, healthcare system burden, consent, and follow-up pathways is crucial.
Further research and pilot testing are necessary before implementing newborn screening for FH.